Skip to main content

Time in Range News

Time in Range (TIR) is the percentage of time that a person spends with their blood glucose levels in the target range, usually between 70 and 180 mg/dl.

Time in range (TIR) is an actionable metric that captures the highs, lows and in-range glucose values that people with diabetes experience each day. Because TIR shows...
A team of world-renowned experts in diabetes presented updates about automated insulin delivery (AID), focusing on the role of diet and exercise for closed-loop systems.
In April 2022, 32 of the world’s premier diabetes experts gathered in Barcelona, along with representatives from industry, advocacy, and regulatory bodies, to discuss...
Clinical trial results published by Lilly show that Tirzepatide could potentially be one of the most effective drugs ever developed for weight loss. Experts discuss...
​For the first time, Time in Range was used as the main outcome measured in a clinical trial for a diabetes medication. Read about the study results and implications.
Find out more from experts about the latest advancements in continuous glucose monitoring, ketone monitors, and non-invasive technologies.
The diaTribe team was on-the-ground in Barcelona, Spain to cover the latest news in diabetes technology from the ATTD 2022 international conference. Here are our top...
At this year’s Advanced Technologies and Treatment conference in Barcelona, diaTribe will bring together dozens of experts in diabetes for a revolutionary consensus...
The diaTribe team is excited to cover all the latest news in diabetes technology and treatments, attending our first in-person diabetes conference in over two years!...
CGMs provide information that you can use to improve your blood glucose. If you don't currently use a CGM, your healthcare team can offer you a “professional” CGM to use...
In March 2022, Dexcom announced that its next-generation continuous glucose monitor (CGM), Dexcom G7, took a significant step towards being available for use in Europe...
Time in Range (TIR) is an effective tool to use in your daily diabetes management, but how can you actually spend more of your day in range? Read below for some helpful...
Time in Range (TIR) is more than just another diabetes metric; it is a tool that can be used to improve communication with your healthcare providers and empower you both...
Each year, the American Diabetes Association updates its Standards of Care, or recommended diabetes practice guidelines. The document includes recommendations for target...
The Eversense E3 continuous glucose monitor (CGM) has been approved by the FDA and it has received a CE Mark approval in Europe for people with diabetes aged 18 and...
In a study of children younger than seven, automated insulin delivery (AID) led to greater Time in Range, less Time above Range, and lower A1C levels.
The American Diabetes Association released its 2022 Standards of Care, which provides an annual update on practice guidelines. Here's what these new updates mean,...
Time in Range (TIR) is a well established and easy to use measurement of your daily glucose management. The glycemia risk index (or dysglycemia index) is an emerging...
Time in Range, or TIR, is quickly becoming a metric everyone is talking about in diabetes. Whether you’re a TIR expert, or you just learned about this new metric, learn...
How can you prevent or slow the progression of diabetic neuropathy with a continuous glucose monitor (CGM)? Research shows that higher Time in Range (TIR) is associated...

Pages